Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mol Cells. 2012 Feb;33(2):203-10. doi: 10.1007/s10059-012-2271-8. Epub 2012 Jan 26.

Moesin is a biomarker for the assessment of genotoxic carcinogens in mouse lymphoma.

Author information

  • 1Department of Biotechnology, Yonsei University, Seoul, 120-749, Korea.

Abstract

1,2-Dibromoethane and glycidol are well known genotoxic carcinogens, which have been widely used in industry. To identify a specific biomarker for these carcinogens in cells, the cellular proteome of L5178Y mouse lymphoma cells treated with these compounds was analyzed by 2-dimensional gel electrophoresis (2-DE) and MALDI-TOF mass spectrometry (MS). Of 50 protein spots showing a greater than 1.5-fold increase or decrease in intensity compared to control cells on a 2-D gel, we focused on the candidate biomarker moesin. Western analysis using monoclonal rabbit anti-moesin confirmed the identity of the protein and its increased level of expression upon exposure to the carcinogenic compounds. Moesin expression also increased in cells treated with six additional genotoxic carcinogens, verifying that moesin could serve as a biomarker to monitor phenotypic change upon exposure to genotoxic carcinogens in L5178Y mouse lymphoma cells.

PMID:
22358511
[PubMed - indexed for MEDLINE]
PMCID:
PMC3887720
Free PMC Article

Images from this publication.See all images (3)Free text

Fig. 1.
Fig. 2.
Fig. 3.
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Publishing M2Community Icon for PubMed Central
    Loading ...
    Write to the Help Desk